Sat.Jun 29, 2024

article thumbnail

STAT+: Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry

STAT

The Food and Drug Administration’s power to make important regulatory decisions is in question after a Supreme Court decision weakening agencies ’ ability to interpret ambiguous statutory measures. The ruling could mean headaches not just for the teams of lawyers and scientists at the FDA, but for the drug and device companies the agency is charged with regulating.

320
320
article thumbnail

How quick medicine delivery is taking prominence in changing Pharma Logistics

Express Pharma

Pharma companies are depending more on external suppliers to manage lean supply chains that can deliver products much faster and with efficiency over long distances. Logistics providers have to meet these requirements, providing a global network for reliable local delivery while abiding by the regulations of each country. For Rita, 28, uploading prescriptions on an App to order medicines for her elderly parents has become a monthly affair.

Diabetes 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: What readers have to say about long Covid, FDA and diversity, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

267
267
article thumbnail

DrugPatentWatch Week in Review

Drug Patent Watch

Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […] Source

91
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Consistently generating £15,000/month in online sales (UPW)

pharmacy mentor

This is a great case of the Ultimate Pharmacy Website (UPW) becoming the hub for the pharmacy, generating consistent monthly revenue, allowing them to grow in completely new directions, alongside their NHS journey About This Pharmacy This is a case study of an NHS DSP pharmacy that approached us over a year ago with ambitious plans for expansion in the digital sphere.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

59

More Trending

article thumbnail

From £0 to £120,000+ per month in 5 months & growing Copy

pharmacy mentor

This Case Study literally blew our minds, and it still does. Dive into how we helped this private DSP go from literally no online presence to making over £120,000 per month, in the space of five months (and they’re growing daily) About This Pharmacy This Private DSP, consisting of Independent Prescribers (IPs), began their journey with us in November 2023.

article thumbnail

PULSE Series Thank you for Payment & Registration

PharmaState Academy

Thank you for your registration! Next Step > Join the WhatsApp group for quick updates. Join WhatsApp Group We will send you the live session Zoom link & other details in your Email. Join WhatsApp Group Happy Learning!

40
article thumbnail

EMCrit 378 – So NSTI – Necrotizing Fasciitis & Life Threatening Soft Tissue Infections

EMCrit Project

Necrotizing Fasciitis and NSTI EMCrit Project by Scott Weingart, MD FCCM.

61
article thumbnail

Participants for START Pilot Program Selected by FDA

PharmaTech

The seven chosen sponsors will help accelerate development of novel drugs and biologics for rare diseases.

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

EU Leads in Biosimilar Market Access While US Lags Behind, Faces Challenges in Adoption

Pharmacy Times

The European Union (EU) has successfully created a competitive market for biosimilars, while the US faces challenging market dynamics and tactics by pharmacy benefit managers that hinder the adoption of lower-cost therapies.

article thumbnail

Which pharmaceutical companies have the most drug patents in Australia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

article thumbnail

Lipid-based novel formulations are advancing menopause management

Express Pharma

Menopause is usually diagnosed clinically when a woman hasn’t menstruated for a year due to a decline in ovarian follicular activity. This condition can generally occur around 45–55 years of age. In India, there are approximately 150 million women experiencing menopause, as per data shared by the Indian Menopause Society (IMS). The average age of menopause in the country is 46.2 years, as compared to the global average of 51 years.